Ignite Creation Date:
2025-12-25 @ 12:52 AM
Ignite Modification Date:
2026-02-21 @ 1:02 PM
Study NCT ID:
NCT01758367
Status:
UNKNOWN
Last Update Posted:
2016-08-31
First Post:
2012-12-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic Leukemia(AML) After Allogeneic Stem Cell Transplantation
Sponsor:
Chinese PLA General Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CN301-XYK-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |